Jan Hillson
Board Member
Eledon Pharmaceuticals, Inc. (ELDN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jan Hillson
Jan Hillson is recorded as Board Member at Eledon Pharmaceuticals, Inc. (ELDN). Eledon Pharmaceuticals, Inc. reported in an 8-K filed June 22, 2023 that Jan Hillson was appointed Class III Director, effective June 21, 2023.
“The stockholders of the Company elected each of David-Alexandre C. Gros, M.D. and Jan Hillson, M.D. as Class III Directors for a three-year term ending at the Annual Meeting of Stockholders to be held in 2026 and until each of their successors has been duly elected and qualified, or until their earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Eledon Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- David-Alexandre "DA" C. Gros, M.D. CEO, Board Member
- David-Alexandre C. Gros CEO, Board Member
- David-Alexandre C. Gros, M.D. CEO, Board Member
- David-Alexandre Gros CEO, Board Member
- Jon Kuwahara CEO
- Paul Little CFO, Chief Accounting Officer
- Bryan Smith General Counsel
- Allan D. Kirk Board Member
- Allan Douglas Kirk, MD, PhD, FACS Board Member
- James Robinson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.